Becton Dickinson and Company (BDX) Stock Price, Quote & News

Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 201 847 6800

Website: www.bd.com

Address:

1 Becton Drive, Franklin Lakes, United States

cor1 May. 26 at 6:51 PM

$BDX

0 · Reply

BillionerOfKing May. 25 at 10:56 PM

$BDX Current Stock Price: $147.64 Contracts to trade: $150.0 BDX Jun 18 2026 Call Entry: $2.85 Exit: $4.57 ROI: 60% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

TalkMarkets May. 20 at 9:14 PM

3 Dividend Stocks For May 2026 $FDS $BDX $TGT https://talkmarkets.com/article/3-dividend-stocks-for-may-2026-1779311640

0 · Reply

STOCKPICKERTRADER May. 20 at 4:31 PM

$BSX BTD on these as equipment sector in healthcare only getting started imo. $MDT $BDX $DHR $IHI

0 · Reply

knowinvest May. 20 at 1:34 PM

$BDX sigh, money is chasing chip stocks again

0 · Reply

CapitalMonk May. 20 at 7:31 AM

$BDX Price: $146.95 (+3.23%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±1.19% RSI: 51.9 | Momentum: Moderate Volume: +22.8% vs avg Volatility: 2.40% Support: $141.82 | Resistance: $157.66 Sourch: http://marketbaubles.com/

0 · Reply

NVDAMillionaire May. 19 at 10:08 PM

$BDX Great piece that accurately captures BDX's current position. So if you want to refresh your understanding of BDX or learn about BDX for the first time, this is essential reading. https://everyticker.com/quote/BDX/analysis/bdx-the-4b-transformation-creating-a-leaner-meaner-medtech-machine-nyse-bdx

0 · Reply

DividendPower May. 18 at 12:48 PM

3 Dividend Stocks for May 2026 https://www.dividendpower.org/dividend-stocks-for-may-2026/ $FDS $BDX $TGT @SureDividend

0 · Reply

knowinvest May. 16 at 6:28 AM

$BDX May be a good defensive play in today's market, along with other players in the $IHI, descent dividend yield too.

0 · Reply

etradebaby May. 15 at 3:41 AM

$BDX stay away

0 · Reply

BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System

May 18, 2026, 11:45 AM EDT - 8 days ago

These 5 Stocks Have 50 Years of Dividend Growth—Here's How to Find More

FUL PEP PPG TNC

May 18, 2026, 6:50 AM EDT - 8 days ago

Peter Menziuso Named EVP and President, BD Interventional

May 15, 2026, 10:36 AM EDT - 11 days ago

AI, Robotics Key to Transforming Health Care: BD CEO

May 12, 2026, 11:40 AM EDT - 14 days ago

Becton, Dickinson and Company Transcript: Bank of America Global Healthcare Conference 2026

2026-05-11T09:42:02.000Z - 15 days ago

Becton Dickinson price target raised to $204 from $202 at Barclays

May 9, 2026, 10:09 AM EDT - 17 days ago

Becton, Dickinson and Company Q2 Earnings Call Highlights

2026-05-07T16:30:04.000Z - 19 days ago

Becton Dickinson names Vitor Roque CFO

May 7, 2026, 8:00 AM EDT - 19 days ago

Becton, Dickinson and Company Earnings Call Transcript: Q2 2026

May 7, 2026, 8:00 AM EDT - 19 days ago

Becton, Dickinson and Company Slides: Q2 2026

May 7, 2026, 8:00 AM EDT - 19 days ago

Becton, Dickinson and Company Earnings release: Q2 2026

May 7, 2026, 8:00 AM EDT - 19 days ago

Becton, Dickinson and Company Quarterly report: Q2 2026

May 7, 2026, 7:57 AM EDT - 19 days ago

Becton Dickinson raises annual profit forecast on strength in drug delivery devices

May 7, 2026, 6:31 AM EDT - 19 days ago

BD Appoints Vitor Roque Chief Financial Officer

May 7, 2026, 6:30 AM EDT - 19 days ago

BD Reports Second Quarter Fiscal 2026 Financial Results

2026-05-07T00:12:46.000Z - 20 days ago

Notable companies reporting before tomorrow’s open

DDOG FUN HWM KVUE MCD PLNT PTON

2026-05-05T13:22:28.000Z - 21 days ago

Becton Dickinson, Wellstar partner for medication management

May 5, 2026, 6:50 AM EDT - 21 days ago

BD and Wellstar Advance Patient Care and Safety with Medication Management Powered by AI

2026-05-04T12:14:39.000Z - 22 days ago

Becton Dickinson resumed with an Outperform at Evercore ISI

2026-05-04T12:08:03.000Z - 22 days ago

Becton Dickinson price target lowered to $163 from $189 at TD Cowen

Apr 30, 2026, 6:50 AM EDT - 26 days ago

BD Achieves Excellence in Employee Well‑Being, Earning Top Industry Recognition

Apr 29, 2026, 6:50 AM EDT - 27 days ago

BD Reimagines Central Line Insertion, Advancing Leadership in Patient Safety Through Breakthrough Vascular Access Technology

Apr 28, 2026, 4:15 PM EDT - 4 weeks ago

BD Board Declares Dividend

Apr 27, 2026, 4:15 PM EDT - 4 weeks ago

BD to Present at Bank of America Securities Health Care Conference

2026-04-17T11:48:57.000Z - 5 weeks ago

Becton Dickinson price target lowered to $159 from $170 at Piper Sandler

Apr 16, 2026, 6:50 AM EDT - 5 weeks ago

BD Earns Industry Top Honors for Transparency, Resiliency and Partnership

2026-04-14T11:36:03.000Z - 6 weeks ago

Becton Dickinson price target lowered to $175 from $195 at RBC Capital

2026-04-10T04:10:13.000Z - 6 weeks ago

Becton Dickinson resumed with a Neutral at Goldman Sachs

Apr 9, 2026, 4:15 PM EDT - 6 weeks ago

BD to Announce Financial Results for its Second Quarter of Fiscal 2026

Apr 9, 2026, 4:05 PM EDT - 6 weeks ago

Rick Byrd to Retire from BD

Apr 9, 2026, 6:50 AM EDT - 6 weeks ago

For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System

2026-04-08T11:23:02.000Z - 6 weeks ago

Becton Dickinson announces CE Mark for Liverty TIPS Stent Graft

Apr 8, 2026, 6:50 AM EDT - 6 weeks ago

BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union

Apr 7, 2026, 6:50 AM EDT - 7 weeks ago

When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight

2026-04-01T10:06:04.000Z - 7 weeks ago

Becton Dickinson launches ai-enabled medication dispensing system in Europe

Apr 1, 2026, 5:00 AM EDT - 7 weeks ago

BD Launches AI-Enabled Medication Dispensing System to the European Market

2026-03-23T13:20:41.000Z - 2 months ago

Becton Dickinson price target lowered to $180 from $230 at Argus

Mar 10, 2026, 8:30 AM EDT - 2 months ago

Becton, Dickinson and Company Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 2, 2026, 6:50 AM EST - 3 months ago

BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound Irrigation

Feb 25, 2026, 4:15 PM EST - 3 months ago

Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase

Feb 25, 2026, 8:00 AM EST - 3 months ago

Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap

Feb 23, 2026, 4:15 PM EST - 3 months ago

BD to Present at Barclays 28th Annual Global Healthcare Conference

Feb 23, 2026, 6:50 AM EST - 3 months ago

BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency

Feb 19, 2026, 4:15 PM EST - 3 months ago

Lanesha Minnix Named General Counsel for BD

Feb 10, 2026, 1:00 PM EST - 3 months ago

Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities

Feb 9, 2026, 8:43 AM EST - 3 months ago

Becton Dickinson cuts annual profit forecast to reflect sale of biosciences and diagnostics unit

Feb 9, 2026, 8:40 AM EST - 3 months ago

BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation

WAT

Feb 9, 2026, 8:40 AM EST - 3 months ago

Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

WAT

Feb 9, 2026, 8:00 AM EST - 3 months ago

Becton, Dickinson and Company Earnings Call Transcript: Q1 2026

Feb 9, 2026, 8:00 AM EST - 3 months ago

Becton, Dickinson and Company Quarterly report: Q1 2026

Feb 9, 2026, 8:00 AM EST - 3 months ago

Becton, Dickinson and Company Earnings release: Q1 2026

Feb 9, 2026, 8:00 AM EST - 3 months ago

Becton, Dickinson and Company Slides: Q1 2026

Feb 9, 2026, 6:30 AM EST - 3 months ago

BD Reports First Quarter Fiscal 2026 Financial Results

Jan 29, 2026, 6:50 AM EST - 4 months ago

BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care

Jan 27, 2026, 4:15 PM EST - 4 months ago

BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26

Jan 27, 2026, 1:00 PM EST - 4 months ago

Becton, Dickinson and Company Transcript: AGM 2026

Jan 27, 2026, 9:26 AM EST - 4 months ago

BD to Announce Financial Results for its First Quarter of Fiscal 2026

Jan 27, 2026, 9:25 AM EST - 4 months ago

BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business

WAT

Jan 27, 2026, 9:25 AM EST - 4 months ago

Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business

WAT

Jan 23, 2026, 6:50 AM EST - 4 months ago

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

Jan 21, 2026, 6:50 AM EST - 4 months ago

BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market

Jan 15, 2026, 6:50 AM EST - 4 months ago

BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System

Jan 14, 2026, 6:50 AM EST - 4 months ago

BD Names Shawn Bevec as Senior Vice President of Investor Relations

Jan 13, 2026, 6:50 AM EST - 4 months ago

BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs

Jan 12, 2026, 4:15 PM EST - 4 months ago

BD To Host Virtual 2026 Annual Meeting of Shareholders

Jan 7, 2026, 12:00 PM EST - 4 months ago

Why The ‘Magnificent 7' Is Out In 2026 And These 3 Dividends Are ‘In'

MA UNP

Jan 5, 2026, 6:50 AM EST - 5 months ago

BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial

Dec 18, 2025, 7:00 AM EST - 5 months ago

Becton, Dickinson and Company Proxy statement: Proxy Filing

Dec 18, 2025, 7:00 AM EST - 5 months ago

Becton, Dickinson and Company Proxy statement: Proxy Filing

Dec 18, 2025, 6:50 AM EST - 5 months ago

BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry

Dec 17, 2025, 2:20 PM EST - 5 months ago

The Magnificent 7 Are So Yesterday. These Are AI's Next Big Winners

BME

Dec 15, 2025, 4:40 PM EST - 5 months ago

BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec

Dec 4, 2025, 6:50 AM EST - 6 months ago

BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories

Dec 3, 2025, 6:50 AM EST - 6 months ago

BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes

cor1 May. 26 at 6:51 PM

$BDX

0 · Reply

BillionerOfKing May. 25 at 10:56 PM

0 · Reply

TalkMarkets May. 20 at 9:14 PM

3 Dividend Stocks For May 2026 $FDS $BDX $TGT https://talkmarkets.com/article/3-dividend-stocks-for-may-2026-1779311640

0 · Reply

STOCKPICKERTRADER May. 20 at 4:31 PM

$BSX BTD on these as equipment sector in healthcare only getting started imo. $MDT $BDX $DHR $IHI

0 · Reply

knowinvest May. 20 at 1:34 PM

$BDX sigh, money is chasing chip stocks again

0 · Reply

CapitalMonk May. 20 at 7:31 AM

0 · Reply

NVDAMillionaire May. 19 at 10:08 PM

0 · Reply

DividendPower May. 18 at 12:48 PM

3 Dividend Stocks for May 2026 https://www.dividendpower.org/dividend-stocks-for-may-2026/ $FDS $BDX $TGT @SureDividend

0 · Reply

knowinvest May. 16 at 6:28 AM

$BDX May be a good defensive play in today's market, along with other players in the $IHI, descent dividend yield too.

0 · Reply

etradebaby May. 15 at 3:41 AM

$BDX stay away

0 · Reply

TrustmeBroseph May. 13 at 1:41 PM

$BDX shit leadership, stale product lineup and bland pipeline. Acquisitions are the only way to show growth or innovation which means debt and further stock decline.

2 · Reply

OfficialStocktwitsUser May. 12 at 7:36 PM

$BDX RSI: 40.38, MACD: -2.8748 Vol: 4.88, MA20: 150.94, MA50: 155.83 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

knowinvest May. 11 at 4:37 AM

$BDX https://finance.yahoo.com/markets/stocks/articles/jim-cramer-becton-dickinson-company-183633038.html

0 · Reply

MarketBeat May. 9 at 2:08 PM

https://marketbeat.com/a/8644325/ $BDX Becton, Dickinson and Company Q2 Earnings Call Highlights

0 · Reply

william64 May. 8 at 2:20 PM

$BDX good company, but this market doesn't give a kwap.

0 · Reply

DonCorleone77 May. 7 at 1:05 PM

$PTON $FUN $TPR $MCD $BDX PRE-MARKET MOVERS: Currently Higher After Earnings: - Datadog (DDOG) up 30.2% - Fortinet (FTNT) up 15.7% - Howmet Aerospace (HWM) up 10.7% - Unity (U) up 8.3% - Warby Parker (WRBY) up 10.1% - Peloton (PTON) up 10.4% - Six Flags (FUN) up 7.2% - Tapestry (TPR) up 3.0% - TripAdvisor (TRIP) up 0.1% Currently Lower After Earnings: - Planet Fitness (PLNT) down 21.5% - Zoetis (ZTS) down 12.8% - Snap (SNAP) down 8.5% - Arm (ARM) down 8.4% - US Foods (USFD) down 6.4% - Coherent (COHR) down 5.1% - Papa John's (PZZA) down 5.5% - Shell (SHEL) down 2.0% - McDonalds (MCD) down 0.1% .

0 · Reply

OpenOutcrier May. 7 at 12:29 PM

$BDX (+2.9% pre) Becton, Dickinson Non-GAAP EPS of $2.90 beats by $0.13, revenue of $4.7B beats by $30M https://ooc.bz/l/101394

0 · Reply

mikesterz7 May. 7 at 12:24 PM

$BDX 🚨🚨🚨 Becton, Dickinson and Company reported fiscal second-quarter 2026 revenue of $4.7 billion, up 5.2% year over year, driven by mid‑single‑digit growth across most businesses. U.S. revenue rose to $2.9 billion and international revenue to $1.8 billion. From continuing operations, BD posted a GAAP diluted loss per share of $(0.13) versus earnings of $0.55 a year ago, reflecting higher integration, restructuring and other specified charges and the impact of discontinued operations. On an adjusted basis, diluted EPS from continuing operations was $2.90, up from $2.79. BD executed a $2.0 billion accelerated share repurchase program and retired $2.1 billion of debt during the quarter. After completing the spin-off of its Biosciences and Diagnostic Solutions business, BD reaffirmed its full‑year 2026 revenue growth outlook and raised its adjusted diluted EPS guidance to a range of $12.52 to $12.72.

0 · Reply

StocktwitsEarnings May. 7 at 10:38 AM

$BDX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$1.11 down -203.74% YoY • Reported revenue of $4.71B down -10.58% YoY • BDX reaffirms its full-year fiscal 2026 revenue growth guidance for low single-digit (FXN) and raises its full-year adjusted diluted EPS guidance to $12.52 to $12.72.

1 · Reply

DonCorleone77 May. 7 at 3:01 AM

$MCD $HWM $DDOG $ZTS $BDX Some notable companies reporting before tomorrow's open, with earnings consensus estimates: - McDonald's (MCD), consensus $2.74 - Howmet Aerospace (HWM), consensus $1.11 - Datadog (DDOG), consensus 51c - Zoetis (ZTS), consensus $1.62 - Becton Dickinson (BDX), consensus $2.77 - Kenvue (KVUE), consensus 26c - Tapestry (TPR), consensus $1.29 - US Foods (USFD), consensus 81c - Unity (U), consensus 24c - Planet Fitness (PLNT), consensus 63c - Warby Parker (WRBY), consensus 11c - Peloton (PTON), consensus 7c - TripAdvisor (TRIP), consensus (7c) - Shell (SHEL), consensus $2.21 - Six Flags (FUN), consensus ($2.74) - Papa John's (PZZA), consensus 37c

0 · Reply

BillionerOfKing May. 6 at 10:09 PM

$BDX Current Stock Price: $144.68 Contracts to trade: $145.0 BDX May 15 2026 Call Entry: $3.80 Exit: $6.01 ROI: 58% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Windee May. 5 at 2:17 PM

$BAX Down over 80% year to date. Looks like they’ll never recover. CAN’T FLOG A DEAD HORSE! Market share seems to have gone to $BDX $MRK $PFE & $ABT

1 · Reply

Market Cap	40.68B
Revenue (ttm)	21.84B
Net Income (ttm)	1.68B
EPS (ttm)	N/A
PE Ratio	10.87
Forward PE	11.71
Profit Margin	7.68%
Debt to Equity Ratio	0.61

Volume	3,243,500
Avg Vol	2,875,422
Day's Range	N/A - N/A
Shares Out	275.54M
Stochastic %K	79%
Beta	0.22
Analysts	Sell
Price Target	$176.25